SCHEMBL27889136

SCHEMBL27889136

CC(C)(C)OC(=O)NC1CCN(CCc2ccc(/C=C/C(=O)O)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.55
SIGMAR1 Q99720 2/20 0.47
DRD2 P14416 5/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
CCR5 P51681 1/20 0.45
KDM1A O60341 1/20 0.43
DRD3 P35462 1/20 0.43
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
DRD4 P21917 2/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928915 0.85 KCNA3 (0.66) KCNA3SIGMAR1DRD2HTR2ACCR5
SCHEMBL26661831 0.84 SIGMAR1 (0.58) KCNA3SIGMAR1DRD2CCR5DRD3
SCHEMBL8257331 0.84 KCNA3 (0.56) KCNA3SIGMAR1DRD2CCR5DRD3
SCHEMBL30401098 0.83 KCNA3 (0.55) KCNA3SIGMAR1DRD2CCR5DRD3
SCHEMBL14119476 0.82 CKS1B (0.48) KCNA3SIGMAR1DRD2HTR2AHTR2C
SCHEMBL14119475 0.82 CKS1B (0.48) KCNA3SIGMAR1DRD2HTR2AHTR2C
SCHEMBL26813618 0.80 SIGMAR1 (0.51) KCNA3SIGMAR1DRD2CCR5DRD3
SCHEMBL18845342 0.80 SIGMAR1 (0.57) KCNA3SIGMAR1DRD2HTR2AHTR2C
SCHEMBL7724067 0.79 KCNA3 (0.59) KCNA3SIGMAR1DRD2CCR5KMT2A
SCHEMBL7724060 0.79 KCNA3 (0.59) KCNA3SIGMAR1DRD2CCR5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102712626-B Piperazine compounds having PGDS inhibitory effect TAIHO PHARMACEUTICAL CO LTD 2014-09-17 CN disclosed
CN-102712626-A Piperazine compounds having PGDS inhibitory effect TAIHO PHARMACEUTICAL CO LTD 2012-10-03 CN disclosed